能特科技 (002102)

HuBei NengTer Technology CO.,Ltd

ASZ

K-Line Chart

No K-line data available

Company NameHubei Nengte Technology Co., Ltd.
Listing Date2006-12-29
Issue Price5.96RMB
Registered Capital247562.67910k RMB
Legal RepresentativeDeng Haixiong
Registered AddressNo. 118 Shenzhen Avenue, Jingzhou Development Zone, Jingzhou City, Hubei Province
IndustryChemical Pharmaceuticals
Main BusinessResearch, development, production, and sales of pharmaceutical intermediates and Vitamin E; Plastic trading e-commerce business; Investment real estate business; Gold mining business; Commercial factoring business.
Company ProfileThe company was established in December 1999 and is a listed company (stock abbreviation: Guanfu Home, stock code: 002102) integrating the R&D, production, sales, and service of household products such as daily-use ceramics, bamboo and wood, glass, and stainless steel. It is a leading domestic daily-use ceramic manufacturing enterprise in terms of production and sales scale, and also the largest high-heat-resistant ceramic production base in China. The company is recognized as a "National Key High-Tech Enterprise," a "High-Tech Enterprise" in Fujian Province, a "Garden-Style Unit," a "Best Credit Enterprise," an "Excellent Enterprise in Ideological Work," one of the "Top 100 Key Industrial Enterprises," and an "Advanced Primary-Level Party Organization."

Stock Details

1. Key Indicators

  • Total Shares(W): 247562.68
  • Circulating A-Shares(W): 217288.40
  • Earnings Per Share(RMB): 0.1743
  • Net Assets Per Share(RMB): 1.3387
  • Operating Revenue(W RMB): 712950.30
  • Total Profit(W RMB): 44992.66
  • Net Profit Attributable to Parent(W RMB): 45280.78
  • Net Profit Growth Rate(%): 276.59
  • Weighted Return on Equity(%): 13.2900
  • Operating Cash Flow Per Share(RMB): 0.0360
  • Undistributed Profit Per Share(RMB): -0.2119
  • Capital Reserve Per Share(RMB): 0.5328

2. Main Business

The main business covers:

  • Research, production, and sales of pharmaceutical intermediates
  • Research, production, and sales of Vitamin E
  • Plastic trade e-commerce business
  • Investment property leasing and operation business
  • Gold mining business

3. Company Basic Information

  • Company Name: HuBei NengTer Technology Co., Ltd.
  • Listing Date: 2006-12-29
  • Industry: Pharmaceutical Manufacturing
  • Address: 9th Floor, Building 8, Chengfa New Era, No. 106 Yuanlin North Road, Shashi District, Jingzhou City, Hubei Province
  • Website: www.guanfu.com
  • Company Profile: The company was established on September 28, 2002, as a joint-stock company transformed from the original Fujian Quanzhou Guanfu Group Co., Ltd. The transformation was approved by the Fujian Provincial Government document Min Zheng Ti Gu [2002] No. 19. The promoters included five natural persons (Lin Fuchun, Lin Wenzhi, Lin Wenchang, Lin Wenhong, Zheng Sufang) who were shareholders of the original Fujian Quanzhou Guanfu Group Co., Ltd., and six legal entities (Fujian Huaxing Venture Capital Co., Ltd., Fujian Henglian Co., Ltd., Dehua County State-owned Assets Investment and Management Company, Fujian Dehua County Qiucun Mining Co., Ltd., Guangzhou Ruihong Trading Co., Ltd., Shanghai Feishi Trading Co., Ltd.).

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hubei Jingjiang Industrial Investment Group Co., Ltd. General Legal Person 33846.31 15.58
2 Beijing Tianyu Zehua IoT Technology Co., Ltd. General Legal Person 5755.01 2.65
3 Guangzhou Jinsu Investment Consulting Center (Limited Partnership) General Legal Person 3701.31 1.70
4 Jingzhou Gucheng State-owned Investment Co., Ltd. General Legal Person 3119.05 1.44
5 Hong Kong Securities Clearing Company Ltd. Northbound Funds 2715.23 1.25
6 Morgan Industry Rotation Hybrid Securities Investment Fund Class A Fund 999.00 0.46
7 Morgan Dual Interest Balanced Hybrid Securities Investment Fund Class A Fund 693.30 0.32
8 Tianhong Value Select Flexible Allocation Hybrid Fund Class A Fund 120.00 0.06
9 Morgan Balanced Select Hybrid Securities Investment Fund Class A Fund 73.30 0.03
10 Hengyue Medical Health Select Hybrid Securities Investment Fund Class A Fund 45.65 0.02

5. Concept Sectors

  • West Coast of the Taiwan Strait
  • Gold Concept
  • Vitamin
  • Synthetic Biology
  • Share Buyback Plan
  • CSI Buyback Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information